Development of an Epidermal Growth Factor Derivative with EGFR Blocking Activity

The members of the epidermal growth factor (EGF)/ErbB family are prime targets for cancer therapy. However, the therapeutic efficiency of the existing anti-ErbB agents is limited. Thus, identifying new molecules that inactivate the ErbB receptors through novel strategies is an important goal on canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Panosa, Clara, Tebar, Francesc, Ferrer-Batallé, Montserrat, Fonge, Humphrey, Seno, Masaharu, Reilly, Raymond M., Massaguer, Anna, De Llorens, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728333/
https://www.ncbi.nlm.nih.gov/pubmed/23935985
http://dx.doi.org/10.1371/journal.pone.0069325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728333/
https://www.ncbi.nlm.nih.gov/pubmed/23935985
http://dx.doi.org/10.1371/journal.pone.0069325

Ejemplares similares